Bud Genius Announces Important Addition to Advisory Board
2015年4月2日 - 9:37PM
ビジネスワイヤ（英語）
Dr. Peter Wilson taught Accounting at Duke
University and served as Director of the Executive MBA
Program
Bud Genius, Inc. (OTC: RIGH), a leading laboratory for cannabis
testing and profiling, developer of data-driven rating systems for
marijuana strains, brand and retail development specialist, and
licensee of celebrity-endorsed marijuana and hemp related
merchandise, announced today an addition to their Executive
Advisory Board.
Peter Wilson, Ph.D., a well known and highly respected expert in
accounting, financial reporting and business law, is joining the
Bud Genius Executive Advisory Board in an official capacity to lend
his expertise and insight as the company enters its rapid growth
phase.
Dr. Wilson has over 25 years of experience in corporate finance
and spent 19 years at Duke University’s Fuqua School of Business
where he was a member of the accounting faculty and also served as
the Director of Executive MBA Programs.
Prior to his time at Duke, Dr. Wilson taught at the Stern School
of Business at New York University in the graduate and
undergraduate programs and also served as the Director of the
Undergraduate Program in Accounting, Taxation and Business Law.
“We are pleased to have Dr. Wilson join our company’s Executive
Advisory Board and look forward to his contributions,” said Angel
Stanz, company CEO. “As an expert in corporate finance, accounting
and financial reporting, Dr. Wilson will provide expertise in areas
that can profoundly impact the future of our company.”
Dr. Wilson holds a BA degree in Philosophy from the University
of North Carolina at Chapel Hill, an MBA degree from
UNC-Greensboro, and a Ph.D. degree in Accounting from the
University of North Carolina at Chapel Hill.
For more information on Bud Genius, call (855) 723-3283, or
visit BGMedtech.com
About Bud Genius:
An early leader in the cannabis industry, Bud Genius is one of
the first established analytical cannabis laboratories in the
United States. Bud Genius launched to bring vendors together with
doctors, patients, and dispensaries that require certified products
held to demanding standards. Bud Genius’ mission is to expand
across the US and abroad, serving as the beacon of quality for
medical cannabis and adult-use marijuana through the formation of
regional laboratories, strain certification, data collection,
online reporting, and product development.
For more information please visit: www.BGMedtech.comVisit the
Bud Genius Cannabis Showroom at: www.BudGenius.com
Connect:
Website: www.BGMedtech.comTwitter:
Twitter.com/BudGeniusCannabis Showroom:
www.BudGenius.com
Forward Looking Statements:
This press announcement includes "forward-looking statements"
within the meaning of the safe harbor provisions of the United
States Private Securities Litigation Reform Act of 1995. These
statements are based upon the current beliefs and expectations of
company’s management and are subject to significant risks and
uncertainties. Forward-looking statements that can be identified by
such terminology such as "believes," "expects," "potential,"
"plans," "suggests," "may," "should," "could," "intends," or
similar expressions. Such forward-looking statements involve known
and unknown risks, uncertainties and other factors that may cause
the actual results to be materially different from any future
results, performance or achievements expressed or implied by such
statements. In particular, management's expectations could be
affected by, among other things, uncertainties relating to our
success in completing acquisitions, financing our operations,
entering into strategic partnerships, competitive factors, and
other matters. Forward-looking statements speak only as to the date
they are made. The Company does not undertake to update
forward-looking statements to reflect circumstances or events that
occur after the date the forward-looking statements are made.
Bud Genius, Inc.Randall HuftPublic
Relations855-723-3283Randall@BudGenius.com
RightSmile (CE) (USOTC:RIGH)
過去 株価チャート
から 10 2024 まで 11 2024
RightSmile (CE) (USOTC:RIGH)
過去 株価チャート
から 11 2023 まで 11 2024
